01 · PRODUCT INFORMATION
About Wolverine Stack 20mg
Wolverine Stack 20mg is a combined research peptide formulation containing BPC-157 10mg and TB-500 10mg in a single lyophilised vial. This product is supplied in the UK by Helix Bio exclusively for controlled laboratory and analytical research.
The name “Wolverine Stack” is commonly used within the research-products sector to describe a formulation combining BPC-157 and TB-500. It is a commercial product name and does not represent an approved therapeutic classification or imply an established medical outcome.
BPC-157 Research Overview
BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids. It has been examined primarily in preclinical and laboratory research involving cellular signalling, vascular responses, cellular migration and experimental tissue-response pathways.
Published research concerning BPC-157 remains predominantly preclinical. Its inclusion in this formulation does not indicate that any proposed effect has been established in humans.
TB-500 Research Overview
TB-500 is a synthetic research peptide associated with thymosin beta-4-related laboratory research. Thymosin beta-4 and related peptide sequences have been examined in experimental models involving actin regulation, cytoskeletal organisation, cellular movement and signalling processes.
Research concerning TB-500 should be distinguished from research conducted on naturally occurring thymosin beta-4. Findings involving one research material should not automatically be attributed to another without appropriate analytical and experimental validation.
Combined BPC-157 and TB-500 Formulation
Wolverine Stack combines BPC-157 10mg and TB-500 10mg in one lyophilised research vial, providing a total peptide content of 20mg.
Existing scientific literature generally examines BPC-157 and thymosin beta-4-related materials independently. The combined Wolverine Stack formulation should therefore be evaluated as a distinct research material. No synergistic, therapeutic or clinical outcome should be assumed.
Product Specifications
-
Product name: Wolverine Stack
-
Individual compounds: BPC-157 and TB-500
-
BPC-157 content: 10mg
-
TB-500 content: 10mg
-
Total vial content: 20mg
-
Unit quantity: One vial
-
Form: Lyophilised solid
-
Product class: Combined research peptide formulation
-
Intended use: Laboratory and analytical research only
Storage and Handling
Wolverine Stack is supplied as a sealed lyophilised solid to support stability during storage and laboratory handling. Store the sealed vial at -20°C, protected from direct light, heat and moisture. Avoid unnecessary temperature cycling.
All storage decisions, material preparation and experimental procedures remain the responsibility of the receiving laboratory and must follow its own validated protocols.
For further information, visit the Helix Bio Peptide Storage and Stability Guide.
Quality Assurance and Batch Documentation
The formulation is produced using controlled peptide-synthesis and lyophilisation processes. Researchers should consult the relevant batch documentation and analytical report when evaluating identity, composition and purity.
Laboratory documentation is being added as independent reports are returned and reviewed. Visit our Certificates of Analysis page to view available reports and current testing status.
Research Use and Safety Information
Helix Bio supplies Wolverine Stack 20mg strictly for scientific, laboratory and analytical research.
This product is not a medicine and is not intended for human consumption, veterinary use, clinical application, diagnosis, treatment or prevention of any medical condition. Helix Bio does not provide medical advice, dosage guidance, administration instructions or therapeutic recommendations.
Important: Helix Bio products are sold strictly for research purposes only. Enquiries concerning personal use or human consumption are prohibited.
Important: Product information is provided for laboratory and analytical research. It does not provide dosing, administration, treatment or human-use guidance.
